Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
I don't know how these jokers sleep at night.
I'm not sure why Gerry Gensler and The SEC hasn't stepped in and shut this turd down.
Lawsuits will expose them for what they are.
In addition to recent long time BOD member jumping ship while the company's in financial duress. SEC frowns upon that also.
Company sale is all fugazi.
Where's ANY of the work results from Sanofi, eTheRNA, IO Biotech, Baylor etc.?
These opossum taint's suffocated news for years while dirty NIH money continued to pay their salaries as they enriched themselves from the insiders.
I've never even received a simple email reply from them EVER.
Commons thrown under the bus while parasites feed off carcass remains.
No winner's is an understatement.
Hope life's good Castaways!
Heartbreaking for a longtime believer and remaining common holder like myself.
I haven't seen the Schedule 13E-3 and Schedule 14C either.
Ulrich Burkhard has done this "going private" rodeo move on another company some years back.
The company resurfaced after a couple years of darkness and investors recouped some of their money back after some venture capital groups acquired it.
"Going private" protects the identity of MYMX's shot callers as bankruptcy would expose them.
It also keeps Mr. Kempers presentable at Biopole.
Enjoy your weekend and keep your head up.
I thought Dr. Ruprecht's NIH work would've been completed by now.
Hope Mr. Kempers will share some good news in the November 10-Q.
"The happiness of your life depends upon the quality of your thoughts." - Marcus Aurelius
Luke 12:2-3
Hello Extrinsic55.
I always used their $82 million Astellas deal as a gauge.
That's coming up on a decade and things change but it was a benchmark.
Since then they've "worked" with Sanofi, eTheRNA, IO Biotech, etc. and a cast of others that followers have never heard the results from their efforts.
The patent with Catalent from MACAVIVA is solid but sits dormant.
Stallergenes approved the Anergis work but still chose to go with alum.
Asthma reduction is a big claim to be made public. No interest from big pharma?
Dr. Peter Hotez had a televised platform and captive audience for two years and never mentioned his MYMX work once.
PCI Biotech?
Were they actually even "working" with these companies?
Audited on taxes and got dropped by BDO. Mom and Pop accounting firm in Spokane, WA took over.
Longtime counsel Ernie Stern jumped ship.
The company that has them up "for sale" doesn't even list them on their web page.
Dr. Thomas Staehelin's run off to the wild, wild west (Serbia).
Mr. Kempers is at the pawn shop with office furniture.
Nobody has this bad of luck.
PCI Biotech, preclinical research collaborator, performs write down of share capital.
September 1, 2023.
https://finance.yahoo.com/news/pci-biotech-write-down-share-090400583.html
https://www.accesswire.com/viewarticle.aspx?id=713978
New address of shared office space has yet to be updated on Mymetics or Biopole website.
+41 216534535
"Net cash provided in investing activities was €92 during the six-months ended June 30, 2023, due to sales of office equipment in Leiden, and €2 used during the same period in 2022, related to new IT equipment in Epalinges." - August 10-Q
Good job on selling used office equipment in Leiden.
Why was new IT equipment in Epalinges needed if all you do is submit three 10-Q's and an annual report?
How about an update on the ongoing final studies of HIV vaccine candidate?
Is Uncle Ulrich relocating back to South America after maximizing shareholder value for common holders?
https://www.marcuardfamilyoffice.com/news/25-years-of-marcuard-family-office/
And where is MFO heading in the next five years?
I’ll leave that question to the younger partners!
Moving Help Needed : August 31st. 9:00AM
Excellent opportunity for Biopole Startup's to get hands on experience of reducing burn rate.
Volunteers requested with a strong back and positive attitude.
Call +41 216534535 if you can assist.
Location:
Biopole
Lysine Building
Route de la Corniche 4
1066 Epalinges
"the office lease agreement for Epalinges has been terminated as of August 31, 2023, and the Company is leasing a shared office space on a three month’s lease basis." - August 2023. 10-Q.
Is leadership trying to intentionally take this company private?
They don't want bankruptcy because it would expose and identify the names on the insider trust.
Dr. Thomas Staehelin could write a check and make it all go away.
Long time holder.
My faith is being challenged today.
I'm not selling at these levels.
Hope tomorrow is a better day for all.
A polyvalent virosomal influenza vaccine induces broad cellular and humoral immunity in pigs
16 August 2023.
Brazil.
https://virologyj.biomedcentral.com/articles/10.1186/s12985-023-02153-5
Thank you Staypositive1.
Did you see MYMX's consortium partner received The King's Award at Buckingham Palace?
What happened to that small percentage of a percentage arrangement with Upperton Pharma?
https://upperton.com/upperton-pharma-solutions-founder-heads-to-buckingham-palace-for-kings-award-honour/
Qubit dephasing Dr. Thomas Staehelin?
Speen Holding AG could parlay MYMX's delivery system to Swiss Rockets.
Hope Gotthard rail tunnel gets rebuilt quickly and glad no one was injured.
8K: "BH has a remaining patent, which the Company expects to acquire to partially compensate for the approximate Euro 6 million accumulated intercompany loans from Mymetics Corporation to BH."
BH actually has two remaining patents on record:
1) Antigen-complexes Bestewil BV. It expires on November 19, 2023.
2) Virosome-like particles Bestewil BV. It expires on December 2, 2023.
Were Toon Stegmann and Jan Wilschut being compensated through these accumulated intercompany loans?
I guess Martin O. Pestalozzi (Ulrich Burkhard) and the offshore trust members are okay with this move.
Thomas Staehelin's favorite biotech is Serbia bound.
July 26, 2023.
Swiss Rockets AG to open an innovation and cancer research centre on BIO4 campus
https://www.serbianmonitor.com/en/swiss-rockets-ag-to-open-an-innovation-and-cancer-research-centre-on-bio4-campus/
"The project has received $500 million in private funding from the family of Dr. Thomas Staehelin and Monique Staehelin."
https://www.forbes.com/sites/moorinsights/2023/07/17/strategic-partnership-between-ionq-and-quantumbasel-could-transform-switzerland-into-a-european-quantum-powerhouse/?sh=1618261845f7
July 17, 2023.
You're welcome Castaways.
I hope life is good my friend.
Enjoy your weekend.
Recombinant HIV compositions and uses thereof in animal models
Patent number: 11684666
Abstract: Provided here are certain recombinant HIV compositions and animal models to evaluate prophylactic and therapeutic antiviral compositions.
Type: Grant
Filed: November 7, 2017
Date of Patent: June 27, 2023
Assignee: University of Louisiana at Lafayette
Inventors: Ruth M. Ruprecht, Samir K. Lakhashe
https://patents.justia.com/inventor/ruth-m-ruprecht
Toon Stegmann. May 24, 2023.
Enhanced HPV16 E6/E7+ tumor eradication via induction of tumor-specific T cells by therapeutic vaccination with virosomes presenting synthetic long peptides.
https://link.springer.com/article/10.1007/s00262-023-03462-y
"These experiments demonstrate that virosomes with Amplivant-SLP and also virosomes with SLP coupled to lipid are suitable for use in therapeutic cancer vaccines, the latter if they also contain the adjuvants QS-21 and 3D-PHAD."
Virosome: An engineered virus for vaccine delivery
May 2023.
Saudi Pharmaceutical Journal
https://www.sciencedirect.com/science/article/pii/S1319016423000749?via%3Dihub
"Hence, due to increasing attention on alum-free antigenic immunization products virosomes are gaining significant consideration."
"The authors extend their appreciation to the Deputyship for Research & Innovation, Ministry of Education in Saudi Arabia for funding this Research work through the project number ISP22-16."
Surfaces with antiviral properties
Watching viruses "burst”
June 15, 2023
Using a novel analytical method, Empa researchers in collaboration with Mymetics have tracked viruses as they pass through face masks and compared their inactivation on the filter layers of different mask types. The new method should now accelerate the development of surfaces that can specifically eliminate viruses [1].
https://analyticalscience.wiley.com/do/10.1002/was.0019000125/
Happy Father's Day!
A missed opportunity not to publicize both the Therakind Dridose and Numaferm GmbH recent work that Dr. Mario Amacker provided.
MYMX is staring down the barrel of OTC extinction as August quickly approaches.
I hope life's good Extrinsic55.
Good summer to all.
Biopôle is delighted to partner with Lenz & Staehelin for LEGAL ESSENTIALS,
LEGAL ESSENTIALS: Relations with stakeholders
July 4, 2023.
https://www.biopole.ch/event/legal-essentials-relations-with-stakeholders/
That's cold hearted with poor optics Dr. Thomas Staehelin!
Therakind’s DriDose® Dry Powder Intranasal Device Delivers Vaccine
March 28, 2023.
https://www.therakind.com/news/therakind-enters-exclusive-distribution-partnership-with-oresund-pharma-lxkzh
"Mario Amacker, Head Manufacturing and Quality of Mymetics, said: “I am very pleased to see that the DriDose® applicator delivered comparable immunogenicity and safety results to our standard applicator in this pre-clinical study of our intra-nasal powder vaccine.”
Action date: 5/17/2023
Action amount: $1,629,815.
COLD CHAIN-INDEPENDENT, NEEDLE-FREE MUCOSAL VIROSOMAL VACCINE TO PREVENT HIV-1 ACQUISITION AT MUCOSAL LEVELS
Budget Year: 6
https://taggs.hhs.gov/Detail/RecipDetail?arg_EntityId=OG0gXGMDRXW5A%2BeI5A9jkQ%3D%3D
PCI Biotech placed a patent application for an undisclosed treatment approach involving fimaVacc that was filed in Q1 2023.
No confirmation of MYMX involvement but the timeline fits.
12 May 2023.
https://www.globenewswire.com/news-release/2023/05/12/2667502/0/en/PCI-Biotech-interim-Q1-2023-results.html
https://www.mymetics.com/media-center/mymetics-and-pci-biotech-sign-preclinical-research-collaboration/
Congratulations to Alexander Kettner for being named Olgram's CSO!
https://www.olgram.com/company/team/
Dr. Kettner was formerly employed with Anergis and played a large role with the COP-virosome allergy work.
"COP-virosomes were the only synthetic therapy able to fully reverse asthma symptoms as well as lung inflammation"
https://www.stallergenesgreer.com/stallergenes-greer-and-anergis-report-successful-preclinical-study-results-cop-virosomes-second
Hello Castaways!
No rumors.
I find it odd that Rock Creek Advisors never posted the purchase opportunity of Mymetics on their company website.
https://www.rockcreekfa.com/blog/
Dr. Thomas Staehelin is proud of uptown Basel and rightfully so. He publicly promotes uptown Basel, Nagel, Swiss Rockets etc. but remains in shadows with Mymetics. Why?
Counselor has a dilemma.
Where are you at Staehelin?
Hospice care for MYMX, while your new girl advances.
Study: COVID Nasal Spray Vaccine Outperforms Shots
April 18, 2023.
https://www.newsmax.com/health/health-news/covid-vaccine-spray/2023/04/18/id/1116603/
https://www.cnn.com/2023/04/03/health/nasal-vaccine-sterilizing-immunity/index.html
https://www.scienceboard.net/index.aspx?sec=sup&sub=can&pag=dis&itemId=5347
Hello Extrinsic55!
Unfavorable optics for Nasir Nahas and Biopole having placed Mr. Kempers on their Scientific Advisory Board for Startups if Mymetics deal isn't completed.
This would be Kempers second consecutive company filing bankruptcy under his leadership, if a deal doesn't materialize.
Kempers name is attached to them, no matter how much he participated in either.
Try spinning that to young startups. Let that marinate.
Has he been enriching himself off of insiders for over a decade?
Kempers has 17 million shares of vested options. He's got skin and his reputation in the game.
Virginity, credit and reputation are only lost once.
Interested to see what Marcel Ruegg (the hired gun) comes up with and if commons are included.
Have a good day.
Agree about the IP stream AhsokaXC.
Seth Berkley, GAVI CEO reaching out to Mario Amacker concerning the published paper last February was validation.
"Even if you have a great idea or invention, you still need to ask yourself: is there a business opportunity? Can my service or product make a difference – in other words, what is the advantage, what issue does it solve? And then, are there people willing to pay for this? This last point is important if you intend to create value and become profitable. Additionally, you need to understand the market you are addressing and current and potential competitors." -Ronald Kempers, Biopole, November 25, 2021
https://www.biopole.ch/story/biopoles-entrepreneurs-share-journey-and-tips-from-ronald-kempers-ceo-and-cfo-at-mymetics/
Have a good one AhsokaXC.
The 10K's have been more detailed since Fruci & Associates replaced BOD as the accountant.
MYMX has never been transparent.
Clandestine company.
I'm interested to see what Marcel Ruegg has come up with for Ulrich Burkhard and Dr. Staehelin.
I hope life is well Castaways.
Thank you GetSeriousOk.
I wish you well on your future endeavors and in life.
Dr. Staehelin certainly has accessibility to capital and the network of Klaus Michael Kuehne and others to consummate a deal.
They could take it private through several combined boutique firms or go the merger/ reverse merger route.
Dr. Ruth Ruprecht's NIH HIV data still hasn't been released.
Much work was put into cleaning the books and recently extending patents.
Have a good day Extrinsic55.
Thank you for the image.
I'll remain on the battlefield.
Gary Gensler's crew should be reviewing this one at this moment.
Later.
"The more silent you are
The more you're able to hear."
-Soren Kierkegaard
Dr. Thomas Staehelin named successor.
13 March 2023
"The child-free Kuehne, 85, who has an estimated net worth of $41.4 billion and is the 29th-richest person in the world (according to the Bloomberg Billionaires Index), has named his closest adviser and vice president of his non-profit Swiss foundation, Thomas Staehelin, as successor."
https://www.campdenfb.com/article/fb-roundup-francoise-bettencourt-meyers-klaus-michael-kuehne-masatoshi-ito
Gratitude to you 46er!
FYI: Former MYMX CEO, current Vaxcyte CEO, Grant Pickering signed a material definitive agreement with Lonza earlier this month.
Hope we get some positive direction today on MYMX's future.